Status:
COMPLETED
Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Acute Myocarditis
Eligibility:
All Genders
Brief Summary
To date, the effects of SARS-Cov-2 (Covid-19) on the myocardium and the role it plays in the evolution towards an acute myocarditis are badly understood. The current pandemic of this emerging virus is...
Detailed Description
Although research on the subject has only recently started developing, the links have already been described between SARS-Cov-2 infection, the severity of the clinical status, and the presence of risk...
Eligibility Criteria
Inclusion
- Patients treated in ICCU or ICU (polyvalent, surgical or medical), in one of the participating hospitals, for symptoms of acute myocarditis confirmed by a myocardial MRI and/or a CT scan and/or a myocardial biopsy. It seems important to include elderly patients who may be under guardianship or curatorship since these patients seem to present the most severe forms. Additionally, the populations most affected by viral myocarditis are generally adolescents and young adults,which justifies including them in the study too. Pregnant women are a population at potentially greater risk, particularly during the third trimester because of the neuro-hormonal changes inherent in pregnancy. This justifies trying to implement the investigator's knowledge through this observational study.
Exclusion
- Refusal to participate.
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 28 2021
Estimated Enrollment :
756 Patients enrolled
Trial Details
Trial ID
NCT04375748
Start Date
April 15 2020
End Date
December 28 2021
Last Update
July 24 2023
Active Locations (65)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology
Aix-en-Provence, France
2
Reanimation
Amiens, France
3
Cardiology
Angers, France
4
Reanimation
Angers, France